Talk:Main Page: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
<div style="display: inline-block; width:100%;"> | <div style="display: inline-block; width:100%;"> | ||
= Welcome to the ''Umbrary'' = | |||
{{Bubble | {{Bubble | ||
Revision as of 06:25, 24 September 2022
Welcome to the Umbrary
About Us
The Umbrary is a private library network curated by Umbra.
- Provide resources for scientists and medical professionals in such areas such as hypermobility and transgender treatment.
- Reduce harm by bringing together official standards of care for gender identities and intersex conditions.
- Enable access to needed information freely to those who require help navigating the systems.
- Showcase accomplishments as a dynamic and growing curriculum vitae.
- Receive requests as a freelance research librarian.
Contact Us
The collection of libraries and lists on this website is curated by Umbra who can be contacted at umbrary@gmail.com.
You can request her services as a research librarian through the form found on the research requests page.
All Pages
Recent Changes
Research Updates
Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study.
This is the first study aiming to investigate the side effects of medroxyprogesterone in the transgender population. The side effects which were self-reported by the population included improved breast development, decreased facial hair, and mood swings. The testing of hormone levels indicated no change in estrogen, yet a decrease in testosterone.
The Papers page is a thorough compendium of up-to-date trans-specific research with a high quality of evidence, as well as guides on ways to access them or find more.
Featured Articles